These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6801539)

  • 1. Anticonvulsant and antiaggressive properties of di-n-propyl acetate after repeated treatment.
    Simler S; Ciesielski L; Klein M; Mandel P
    Neuropharmacology; 1982 Feb; 21(2):133-40. PubMed ID: 6801539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of di-n-propylacetate, gabaculine, and aminooxyacetic acid: anticonvulsant activity and the gamma-aminobutyrate system.
    Wood JD; Kurylo E; Tsui SK
    J Neurochem; 1981 Dec; 37(6):1440-7. PubMed ID: 6801201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant activity of di-n-propylacetate and brain monoamine metabolism in the rat.
    Abed WT
    Clin Exp Pharmacol Physiol; 1990 Jan; 17(1):11-6. PubMed ID: 1693553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin potentiates the anticonvulsant and antinociceptive effects of valproic acid and pregabalin in pentylenetetrazole-kindled mice.
    Hamada NM; Ashour RH; Shalaby AA; El-Beltagi HM
    Eur J Pharmacol; 2018 Jan; 818():351-355. PubMed ID: 29104044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine and GABA metabolism and the anticonvulsant action of di-n-propylacetate and ethanolamine-O-sulphate.
    Horton RW; Anlezark GM; Sawaya MC; Meldrum BS
    Eur J Pharmacol; 1977 Feb; 41(4):387-97. PubMed ID: 139317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of gamma-aminobutyric acid (GABA) in mice with audiogenic seizures.
    Anlezark G; Horton RW; Meldrium BS; Sawaya CB
    Biochem Pharmacol; 1976 Feb; 25(4):413-7. PubMed ID: 779794
    [No Abstract]   [Full Text] [Related]  

  • 7. The modification of the ethanol withdrawal syndrome in rats by di-n-propylacetate.
    Noble EP; Gillies R; Vigran R; Mandel P
    Psychopharmacologia; 1976 Mar; 46(2):127-31. PubMed ID: 781711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Di-n-propylacetic acid--profile of anticonvulsant activity in mice.
    Frey HH; Löscher W
    Arzneimittelforschung; 1976 Feb; 26(2):299-301. PubMed ID: 779804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the role of serotonin in different regions of the rat central nervous system on pentylenetetrazol-induced seizures and the effect of di-n-propylacetate.
    Lazarova M; Bendotti C; Samanin R
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Mar; 322(2):147-52. PubMed ID: 6408491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of analogues of valproic acid on seizures induced by pentylenetetrazol and GABA content in brain of mice.
    Keane PE; Simiand J; Mendes E; Santucci V; Morre M
    Neuropharmacology; 1983 Jul; 22(7):875-9. PubMed ID: 6413882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of sodium dipropylacetate on experimental convulsions produced by pentetrazole and picrotoxin].
    Ciesielski L; Simler S; Mandel P
    C R Seances Soc Biol Fil; 1981; 175(1):109-13. PubMed ID: 6452930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual role for GABA in quasi-morphine abstinence behavior induced by di-n-propylacetate involving both initiation and termination.
    Van der Laan JW; Bruinvels J
    Psychopharmacology (Berl); 1981; 74(2):143-8. PubMed ID: 6791219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Di-n-propylacetate-induced abstinence behaviour as a possible correlate of increased GABA-ergic activity in the rat.
    de Boer T; Bartels K; Metselaar HJ; Bruinvels J
    Psychopharmacology (Berl); 1980; 71(3):257-67. PubMed ID: 6779333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of gamma-aminobutyric acid (GABA)-elevating agents on the neuroleptic-induced activation of striatal tyrosine-hydroxylase: evidence that di-n-propylacetate augments GABAergic neurotransmission.
    Casu M; Gale K
    J Pharmacol Exp Ther; 1981 Apr; 217(1):177-80. PubMed ID: 6110774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of n-di-propylacetate on aggressive behavior and brain GABA level in isolated mice.
    Simler S; Puglisi-Allegra S; Mandel P
    Pharmacol Biochem Behav; 1983 May; 18(5):717-20. PubMed ID: 6407034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: gamma-Aminobutyric acid metabolism and the anticonvulsant action of ethanolamine-o-sulphate and di-n-propylacetate.
    Anlezark GM; Horton RW; Meldrum BS; Sawaya MC; Stephenson JD
    Br J Pharmacol; 1976 Mar; 56(3):383P-384P. PubMed ID: 769882
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the mechanism of action of valproid acid].
    Löscher W; Frey HH
    Arzneimittelforschung; 1977; 27(5):1081-2. PubMed ID: 328017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of di-n-propylacetate on the 'binding of GABA to synaptosome-enriched fraction of rat cerebral cortex.
    Kulig BM; Gonzalez-Portal C; Somoza E; Defeudis FV
    Psychopharmacology (Berl); 1977 Aug; 53(3):255-7. PubMed ID: 408853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute anticonvulsant activity of structural analogues of valproic acid and changes in brain GABA and aspartate content.
    Chapman AG; Meldrum BS; Mendes E
    Life Sci; 1983 Apr; 32(17):2023-31. PubMed ID: 6403794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anticonvulsant action of GABA-elevating agents: a re-evaluation.
    Wood JD; Peesker SJ
    J Neurochem; 1975 Sep; 25(3):277-82. PubMed ID: 1159424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.